Results 331 to 340 of about 160,741 (387)

Physiological and Biochemical Parameters of Premenopausal and Postmenopausal Women in Samarra, Iraq

Abeer hassan
openalex   +1 more source

ISUOG Consensus Statement on sonographic assessment of the endometrium: how to perform a gynecological ultrasound scan and report the findings

Ultrasound in Obstetrics &Gynecology, Volume 67, Issue 2, Page 241-258, February 2026.
T.  Van den Bosch, R.  Heremans, C.  Landolfo, E.  Epstein, F. P. G.  Leone, T.  Bourne, D. Timmerman, Collaborators, J. Preisler, O. Rotenberg, H. Marret, G. Condous, J. L. Alcázar, D. Fischerová, U. Metzger, C. Van Pachterbeke, D. Franchi, M. Nisolle, J. Huirne, C. Fotopoulou, S. Goldstein   +20 more
wiley   +1 more source

Some of the next articles are maybe not open access.

Related searches:

Gut-microbiome-expressed 3β-hydroxysteroid dehydrogenase degrades estradiol and is linked to depression in premenopausal females.

Cell Metabolism, 2023
Estradiol decline can result in depressive disorders in females; nevertheless, the causes of this decline are unclear. In this study, we isolated estradiol-degrading Klebsiella aerogenes from the feces of premenopausal females with depression.
Di Li, Ting Sun, Y. Tong, Juan Le, Qian Yao, Jun Tao, Hang Liu, W. Jiao, Yufeng Mei, Jingru Chen, Zhongchun Liu, Gaohua Wang, Yan Li   +12 more
semanticscholar   +1 more source

Premenopausal osteoporosis

Climacteric, 2021
In premenopausal women, bone mineral density measurement by dual-energy X-ray absorptiometry should not be used as the sole guide for diagnosis or treatment of osteoporosis, universal screening with bone mineral density is not advised and the World Health Organization classification of bone status should not be applied.
M. Conradie, T. de Villiers
openaire   +2 more sources

Ribociclib plus endocrine therapy for premenopausal women with hormone-receptor-positive, advanced breast cancer (MONALEESA-7): a randomised phase 3 trial.

The Lancet Oncology, 2018
BACKGROUND In MONALEESA-2, ribociclib plus letrozole showed improved progression-free survival compared with letrozole alone as first-line treatment for postmenopausal patients with hormone receptor (HR)-positive, HER2-negative, advanced breast cancer ...
D. Tripathy, S. Im, M. Colleoni, F. Franke, A. Bardia, N. Harbeck, S. Hurvitz, L. Chow, J. Sohn, K. Lee, S. Campos-Gómez, R. Villanueva Vázquez, K. Jung, K. Babu, P. Wheatley-Price, M. De Laurentiis, Y. Im, S. Kuemmel, N. El-Saghir, Mei-Ching Liu, G. Carlson, G. Hughes, I. Díaz-Padilla, C. Germa, S. Hirawat, Yen-Shen Lu   +25 more
semanticscholar   +1 more source